# Renewal Weekly Writing Style Guide

Use this document as a reference when generating new content. Copy relevant sections into your AI prompts to maintain consistency.

---

## THE VOICE IN ONE SENTENCE

**"A smart friend who happens to read medical journals explaining what actually matters—hopeful but never naive, accessible but never dumbed down."**

---

## CORE TONE PRINCIPLES

### 1. Confident but Not Preachy
❌ "You should really consider..."
❌ "It's important to remember that..."
✅ "Here's what that means for you:"
✅ "The short version:"

### 2. Direct, Not Clinical
❌ "The study demonstrated statistically significant improvements in visual acuity metrics."
✅ "Patients didn't just stabilize. They got better."

### 3. Hopeful, Not Hype
❌ "This miracle breakthrough could cure everything!"
❌ "Revolutionary treatment changes everything!"
✅ "That changed this week."
✅ "The results are genuinely encouraging."

### 4. Smart, Not Academic
❌ "Mesenchymal stem cells (MSCs) derived from adipose tissue..."
✅ "MSC therapy for MS is still considered experimental and isn't covered by insurance."

### 5. Human, Not Corporate
❌ "We are pleased to present this week's findings."
✅ "Good morning. It's the week before Thanksgiving, which means you're probably already mentally budgeting for elastic waistbands."

---

## SENTENCE STRUCTURE PATTERNS

### The Contrast Setup
Use short punchy sentence after longer context:

> "For 20 million Americans with age-related macular degeneration, the prognosis has always been the same: We can slow it down, but we can't bring back what you've lost.
>
> **That changed this week.**"

### The "Here's what" Formula
Break down complex info with clear labels:

> **Here's what happened:** Patients in the low-dose group gained the ability to read 21 additional letters on a standard eye chart.
>
> **Why this matters now:** The treatment uses adult stem cells—sidestepping the ethical debates that have slowed embryonic stem cell research.
>
> **What's next:** The team is now monitoring 12 patients who received higher doses.

### The Relatable Translation
Always follow technical info with real-world meaning:

> "...gained the ability to read 21 additional letters on a standard eye chart after one year. **For context, that's the difference between needing help crossing the street and reading a restaurant menu.**"

### The Honest Caveat
Acknowledge limitations without being negative:

> "**The catch:** Results varied based on how cells were delivered and where the MSCs came from. There's no standardized protocol yet."
>
> "**What you should know:** MSC therapy for MS is still considered experimental and isn't covered by insurance."

---

## SECTION-BY-SECTION STYLE

### Opening Hook
- **Length:** 50-75 words
- **Structure:** Observation → Reframe → Hand-off
- **Tone:** Warm, slightly self-deprecating, seasonal
- **Never:** Mention stem cells or medical content
- **Always:** End with "—The Renewal Weekly Team"

**Example:**
> Good morning. It's the week before Thanksgiving, which means you're probably already mentally budgeting for elastic waistbands.
>
> Here's a thought: What if instead of dreading the "holiday pounds," you focused on the one thing that actually matters—showing up for the people you love, however you feel?
>
> We'll handle the health intel. You handle the mashed potatoes.
>
> —The Renewal Weekly Team

**Pattern to copy:**
- Line 1: Relatable seasonal observation (light humor)
- Line 2-3: Gentle reframe that connects to health/wellbeing
- Line 4: Hand-off that positions newsletter as helpful partner

---

### The Bottom Line (TL;DR)
- **Length:** 4 bullet points
- **Structure:** Arrow → Key takeaway
- **Tone:** Scannable, punchy, benefit-focused
- **Each bullet:** One clear insight, no fluff

**Example:**
> → Stem cells just restored vision in AMD patients—first time ever
> → MSC therapy shows promise for MS, but costs $5K-$30K out of pocket
> → Anti-inflammatory foods beat supplements (Harvard agrees)
> → The regenerative medicine market is about to explode to $400B

---

### Lead Story
- **Length:** 350-400 words
- **Structure:** Hook → What happened → Why now → What's next → Zoom out
- **Headlines:** Clever but clear, no clickbait

**Good headlines:**
- "Stem Cells Just Did What Doctors Said Was Impossible"
- "The Anti-Inflammatory Shopping List You Actually Need"

**Bad headlines:**
- "BREAKING: Miracle Cure Found!"
- "You Won't Believe What Scientists Discovered"

**Opening patterns:**
> "For [X million] Americans with [condition], the prognosis has always been the same: [limitation]. That changed this week."

> "The [industry/field] wants you to believe [common assumption]. [Authoritative source] disagrees."

**Closing pattern (Zoom out):**
> "This is exactly the kind of rigorous, FDA-tracked research that separates real regenerative medicine from the clinics promising miracle cures."

---

### Research Roundup
- **Length:** 100-150 words
- **Tone:** Practical, actionable, honest about limitations
- **Always include:** Cost range, availability, key caveat

**Pattern:**
> If you or someone you love has [condition], this one's worth reading twice.
>
> [What the research found—2-3 sentences]
>
> **What you should know:** [Practical reality—cost, availability, insurance]
>
> **The catch:** [Honest limitation or caveat]
>
> **Bottom line:** [Actionable next step]

---

### On Our Radar (Secondary Stories)
- **Length:** 75-150 words each
- **Structure:** Bold lead hook + expansion
- **Bold lead:** Complete thought that could stand alone

**Good bold leads:**
- "Stanford just made stem cell transplants safer—without chemo."
- "Type 1 diabetes was cured in mice. Humans might be next."
- "MSC trials are up 37% in 2025—and investment is following."

**Pattern:** [Subject] + [did what] + [surprising element/result]

---

### Deep Dive
- **Length:** 200-250 words
- **Tone:** Practical guide, not lecture
- **Structure:** Contrarian opening → Evidence → Actionable lists → Connection to stem cells

**Opening patterns:**
> "The [industry] wants you to believe [common belief]. [Source] disagrees."
> "You've probably heard [common advice]. Here's what actually works."

**List format:**
> **What to add:**
> • Fatty fish (salmon, sardines, mackerel) — 2-3 servings/week
> • Extra virgin olive oil — your new default cooking fat

**Closing pattern (connect to regenerative health):**
> "**The connection to stem cells:** Chronic inflammation damages bone marrow and accelerates stem cell aging. What you eat doesn't just affect how you feel today—it affects how well your body regenerates tomorrow."

---

### Stat of the Week
- **Tone:** Awe-inspiring but grounded
- **Structure:** Big number → What it means → Scale comparison → Why it matters for reader

**Example:**
> **$403.86B**
> *where the regenerative medicine market is headed by 2032*
>
> That's not a typo. The regenerative medicine market is projected to grow from $48 billion today to over $400 billion in the next seven years—a 27.3% annual growth rate.
>
> **Why it matters for you:** More investment means more trials, faster approvals, and eventually, more affordable treatments.
>
> **Translation:** The treatments we're writing about today may be routine options in a decade.

---

### The Pulse (Quick Hits)
- **Length:** Under 25 words each
- **Structure:** Fact + [Source, Date]
- **Tone:** Newswire brevity

**Good:**
> "Takeda launched a new autologous stem cell therapy for cartilage regeneration in Japan this month"

**Bad:**
> "In exciting news, Takeda has announced the launch of an innovative new therapy..." (too wordy)

---

### Worth Knowing
- **Tone:** Protective big sibling
- **Focus:** Red flags, practical guides, resources

**Red flags format:**
> **5 Red Flags When Choosing a Stem Cell Clinic**
> (1) They claim to treat everything from wrinkles to MS with the same cells.
> (2) They use "amniotic" or "exosome" products without explaining what's actually in them.
> (3) They rely entirely on testimonials instead of published data.
> (4) They're not FDA-compliant or won't discuss it.
> (5) They offer IV stem cell treatments (currently forbidden by the FDA).

---

## WORDS & PHRASES TO USE

| Instead of... | Write... |
|---------------|----------|
| Revolutionary | Genuinely encouraging |
| Breakthrough | Changed this week |
| You should | Here's what that means |
| It's important to note | The catch: |
| Studies show | [Source] found that |
| Significant improvement | Got better |
| May help with | Shows promise for |
| Consult your doctor | Ask your neurologist about |
| Click here | [Embedded link in context] |

---

## WORDS & PHRASES TO AVOID

- "Miracle" / "Cure" / "Revolutionary"
- "You won't believe..."
- "Scientists are excited..."
- "This changes everything"
- "In conclusion..."
- "As we all know..."
- "It goes without saying..."
- "At the end of the day..."
- Corporate jargon (leverage, synergy, optimize)
- Excessive exclamation points!!!

---

## LINK STYLE

**Always embed links in natural reading flow:**

❌ "Read the study here: [link]"
❌ "Source: University of Michigan (link)"
✅ "Researchers at the {{LINK:University of Michigan|url}} published results..."
✅ "The full study was published in {{LINK:Cell Stem Cell|url}}."

**Link the most meaningful words:**
- ❌ "{{LINK:Click here|url}} to read more"
- ✅ "The {{LINK:anti-inflammatory diet guide|url}} from Johns Hopkins"

---

## FORMATTING RULES

1. **Bold for structure:** "**Here's what happened:**" "**The catch:**" "**Why it matters:**"
2. **Em dashes for asides:** "—sidestepping the ethical debates" not "(sidestepping the ethical debates)"
3. **Colons before explanations:** "The prognosis has always been the same: We can slow it down."
4. **Short paragraphs:** 2-3 sentences max in most sections
5. **Bullet points:** Use • not - for lists, keep parallel structure

---

## THE TRUST TEST

Before publishing any content, ask:

1. **Would I send this to my parent with arthritis?** (Is it clear and respectful?)
2. **Would a doctor cringe?** (Is it accurate without overpromising?)
3. **Would a skeptic roll their eyes?** (Is it honest about limitations?)
4. **Would a scanner get value?** (Can someone skim and learn something?)
5. **Would I click the links?** (Are they genuinely useful?)

---

## PROMPT TEMPLATE FOR AI GENERATION

When asking Claude (or any AI) to write content, include this context:

```
Write in the Renewal Weekly style:
- Voice: Smart friend who reads medical journals, hopeful but never naive
- Tone: Confident but not preachy, direct but not clinical
- Structure: Use "Here's what happened" / "Why this matters" / "The catch" labels
- Links: Embed using {{LINK:display text|url}} syntax
- Honesty: Always include costs, availability, and limitations
- Translation: Follow technical info with real-world meaning
- Length: [specify word count for section]

Audience: Adults 40-80 with chronic conditions researching treatment options. They're smart, skeptical, and tired of hype.
```

---

## SAMPLE CONTENT FOR REFERENCE

### Perfect Opening Hook
> Good morning. It's the week before Thanksgiving, which means you're probably already mentally budgeting for elastic waistbands.
>
> Here's a thought: What if instead of dreading the "holiday pounds," you focused on the one thing that actually matters—showing up for the people you love, however you feel?
>
> We'll handle the health intel. You handle the mashed potatoes.
>
> —The Renewal Weekly Team

### Perfect Lead Story Opening
> For 20 million Americans with age-related macular degeneration, the prognosis has always been the same: We can slow it down, but we can't bring back what you've lost.
>
> That changed this week.
>
> Researchers at the {{LINK:University of Michigan|https://www.sciencedaily.com/releases/2025/11/251121090736.htm}} published results from the first-ever human trial using adult stem cells to treat advanced dry AMD—and patients didn't just stabilize. They got better.

### Perfect Practical Caveat
> **What you should know:** MSC therapy for MS is still considered experimental and isn't covered by insurance. Most patients access it through clinical trials or private clinics abroad. Costs range from $5,000–$30,000 depending on the protocol.
>
> **The catch:** Results varied based on how cells were delivered (IV vs. spinal injection) and where the MSCs came from. There's no standardized protocol yet.
>
> **Bottom line:** If you're considering this route, ask your neurologist about active clinical trials on ClinicalTrials.gov before exploring private options.

---

Add this file to your repository and reference it in every content generation prompt.
